Atrial Fibrillation Is . . .

. . . Dangerous
Atrial fibrillation is an abnormal heart rhythm in which the heart beats both rapidly and irregularly. While a normally functioning heart beats at 60-80 beats/minute, a heart in atrial fibrillation beats at 120-180 beats/minute. At this rate, the heart cannot effectively contract enough to pump blood to the rest of the body, causing symptoms ranging from shortness of breath to heart failure.

. . . Increasing
Approximately 6 million people worldwide experience atrial fibrillation. It is the most common sustained arrhythmia and is a major cause of stroke among the elderly.

. . . Controllable
Aderis Pharmaceuticals is developing a selectively-acting, adenosine-based therapeutic, Selodenoson, to control heart rate during atrial fibrillation. We believe that Selodenoson is the only adenosine-based product in development that can be formulated for both IV and oral administration, enabling its use for both acute attacks and chronic management. For more information about this novel product, Selodenoson, click here.

For a list of web sites providing more information about cardiovascular diseases, click here.

back to top

---